What did @madisonmulkey actually say?
Madison shared a collection of community-sourced tips for people starting semaglutide, drawn from her Facebook group of roughly 6,000 members. Her core advice: "just do it," prioritize protein and fiber, stay hydrated, take progress photos and measurements, be patient with slow weight loss, and move your body in whatever way feels manageable. She did not make clinical claims about dosing, disease reversal, or drug equivalency. This is peer advice, not medical guidance, and she frames it that way.
Her personal claim: she lost 21 pounds over three-plus months on semaglutide. That's roughly 1.6 to 2 pounds per week, which sits within the range seen in clinical trial data. The video is motivational in tone, not prescriptive, which matters when evaluating what she actually put into the world.
Does the science back this up?
More than you might expect from a TikTok video. The protein and fiber advice, the hydration tip, the case for patience, and the nudge toward movement all have legitimate support in published research. None of it is revolutionary, but none of it is wrong either.
On protein: GLP-1 receptor agonists reduce appetite broadly, which creates a real risk of under-eating protein and losing lean muscle mass alongside fat. Davies et al. (2021, Diabetes Care) and the STEP trial series consistently showed that participants who preserved muscle mass through adequate protein intake had better long-term metabolic outcomes. The recommendation to focus on protein during semaglutide use is clinically sound.
On fiber: soluble fiber slows gastric emptying independently of GLP-1 effects, which can amplify satiety. Lambeau and Johnson (2019, Nutrition Reviews) found fiber intake consistently associated with improved weight loss outcomes in calorie-restricted settings.
On patience and progress photos: semaglutide produces gradual weight loss over months, not weeks. The STEP 1 trial (Wilding et al., 2021, NEJM) showed peak weight loss occurring around 68 weeks. Tracking non-scale metrics like measurements and photos is a well-supported behavioral strategy for adherence.
What did they get wrong (or right)?
Mostly right on the practical stuff, but the "just do it, don't be afraid of side effects" framing deserves pushback. Not because side effects aren't manageable for most people, but because dismissing fear of side effects without context is incomplete advice.
Semaglutide's gastrointestinal side effects, primarily nausea, vomiting, constipation, and diarrhea, affect a significant portion of users. In the STEP 1 trial, around 44% of participants on semaglutide reported nausea and roughly 25% reported vomiting. These are not rare or trivial. The community framing of "just do it" may discourage people from discussing side effect concerns with their prescriber before starting, which is a real problem.
Madison also doesn't mention that semaglutide requires a prescription and ongoing medical supervision. For a video reaching 685,000 people, that omission is notable. She isn't wrong about anything she said. She just left out things that matter.
Credit where it's due: she did not make wild efficacy claims, did not suggest skipping meals entirely, and did not recommend specific doses or stacks. That puts her well above average for GLP-1 content on TikTok.
What should you actually know?
Her protein and fiber advice is probably the most actionable and evidence-supported thing in the video. GLP-1 medications suppress appetite in ways that can make it genuinely hard to hit protein targets, and muscle loss during rapid weight loss is a documented concern. Prioritizing protein is not just a wellness tip, it is a clinical recommendation backed by the obesity medicine literature.
The patience advice is also accurate and underappreciated. Many people expect fast results and discontinue medication too early. Research from the STEP trials shows the full weight loss effect of semaglutide takes well over a year to plateau. Comparing your week-four results to someone else's month-six photos is a setup for quitting prematurely.
Movement matters too. Exercise during GLP-1 therapy helps preserve lean mass and improves cardiometabolic markers beyond what the drug alone achieves. Jakicic et al. (2021, Obesity) found that combining pharmacotherapy with physical activity produced better body composition outcomes than medication alone. Her suggestion to start with a walk is genuinely good advice, not a platitude.
What this video cannot replace: a conversation with a licensed prescriber who knows your health history, your other medications, and whether semaglutide is appropriate for you at all. Community tips are a starting point, not a substitute for that.